Navigation Links
Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
Date:6/24/2013

HAYWARD, Calif., June 24, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with autoimmune disorders, today announced it has initiated the BRIGHT-SC Phase 2 study of blisibimod, a novel inhibitor of B-Cell Activating Factor (BAFF) for the treatment of IgA nephropathy. IgA nephropathy is a chronic autoimmune renal disease characterized by proteinuria and progression to end stage renal disease.

BRIGHT-SC is a multicenter, placebo-controlled, double-blind, Phase 2 clinical study that is expected to enroll at least 48 patients from Asia Pacific geographies. Patients will be randomized into one active treatment arm or one placebo arm. The primary endpoint of the study will be a reduction in proteinuria at 32 weeks. The Company plans to conduct an interim analysis of proteinuria after patients have completed 8 weeks of therapy. Secondary endpoints will include the effects of blisibimod on estimated Glomerular Filtration Rate (eGFR), plasma B cells, and other biomarkers of kidney disease.

In May, the company met with the US FDA to discuss the future of the IgA nephropathy development plan. "We are encouraged by the outcome of our pre-Investigational New Drug meeting with the FDA. The use of proteinuria as a primary endpoint in studies of IgA nephropathy was well received by the agency," said Paula Adams, PhD, Anthera's Vice President of Regulatory Affairs and Compliance. "Data from the BRIGHT-SC study design will be helpful in our efforts to obtain an accelerated approval for blisibimod in this potential orphan indication." In the coming weeks the Company will be meeting with the Japanese Pharmaceutical Medical Devices Agency to explore development strategies in Japan.'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
2. Anthera Announces First Quarter 2012 Financial Report and Conference Call
3. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
4. Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
5. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
6. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
7. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
8. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
10. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
11. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)...   Intarcia Therapeutics, Inc. today announced the ... President, Human Resources, reporting directly to Kurt Graves ... key member of the senior leadership team, Mr. Brady ... to assure the Company advances its business, brings in ... values and its dynamic culture. Another essential goal for ...
(Date:5/1/2015)... 1, 2015 CANTEL MEDICAL CORP. (NYSE: CMN ... Executive Officer, will be presenting at the Bank of America ... Wynn in Las Vegas, NV. The ... 10:00 AM PT/1:00 PM ET. In addition, management will be ... An audio webcast will be available via the investor ...
(Date:5/1/2015)... , May 1, 2015  Portal Instruments, Inc., an ... systems, announced today that Robert Langer, Sc. D., ... University of Auckland Distinguished Professor have joined the company,s ... welcome two esteemed biotechnology leaders, Professor Robert Langer ... team," said Dr. Patrick Anquetil , Chief Executive ...
Breaking Medicine Technology:Intarcia Appoints James P. Brady Vice President, Human Resources 2Intarcia Appoints James P. Brady Vice President, Human Resources 3Intarcia Appoints James P. Brady Vice President, Human Resources 4Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 2Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 4
... March 1, 2011 Practice Fusion, the ... in the US, today announced Jason Portnoy as the ... free, cloud-based EMR to physicians; enabling charting, scheduling, e-prescribing ... period of rapid expansion, bringing his deep expertise in ...
... IRVINE, Calif., March 1, 2011 Uptake Medical ® ... of lung diseases including emphysema , announced today that ... (Nasdaq: VOLC ) has joined the company,s Board ... CEO and Director of Volcano since April 2002. He led ...
Cached Medicine Technology:Former PayPal, Palantir Executive Jason Portnoy Joins Practice Fusion as CFO 2Former PayPal, Palantir Executive Jason Portnoy Joins Practice Fusion as CFO 3Uptake Medical Announces Scott Huennekens Elected to Board of Directors 2
(Date:5/3/2015)... Indiana Fiber Network, LLC (IFN), the ... Services, Inc (BCS) has selected IFN as a fiber ... technology, service, and working relationship with IFN has been ... feel you get with IFN. I like dealing ... local decisions and operates as a local community business ...
(Date:5/3/2015)... Boston, MA (PRWEB) May 03, 2015 ... received clearance from the FDA to produce and market ... This device can be used in outpatient settings and ... , The alternate posterior approach has been extensively researched ... a 510k approval to use this approach in conjunction ...
(Date:5/2/2015)... 02, 2015 Ticket Down has secured additional ... the long awaited event today, Saturday, May 2nd at the ... fans will be able to secure tickets for both the ... that boxing fans have wanted for more than five years ... “Money” Mayweather will step inside the ring to fight Manny ...
(Date:5/2/2015)... May 02, 2015 It’s a pattern ... natural disaster strikes anywhere on this planet, cyber scammers ... sympathy and compassion for their own personal gain. ... Emergency Readiness Team) issued an alert titled “Nepal ... email scams citing the earthquake in Nepal. The scam ...
(Date:5/2/2015)... Kare Visits LLC. launched in Chicago in response to the ... offers relief for caregivers by visiting loved ones in nursing ... the Caregiver Action Network, eight in ten caregivers are employed. ... caring for an elderly or disabled loved one. For ... caregiver is now empowered to schedule an on demand visit ...
Breaking Medicine News(10 mins):Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2
... ... Vouchers Via Twitter to Support the Launch of the New Video Marketing Quiz. , ... (PRWEB) March 9, 2010 -- EyeView , the ... Video Marketing Quiz on Wednesday March 10, 2010 at 10 am ET. The ...
... ... combined their industry leading technologies to provide the most sensitive tools for monitoring apoptosis in ... ... have combined their industry leading technologies to provide the most sensitive tools for monitoring apoptosis ...
... ... ... ... ...
... ... ... ... ...
... when the price went up, study found , TUESDAY, March ... people consume less of it, a new study has found. , ... adults, aged 18 to 30, beginning in 1985 to 1986 and ... percent increase in price was associated with a 7 percent decrease ...
... ... employees and positive business outcomes. , ... Charlotte, NC (Vocus) March 9, 2010 -- Morehead , the ... free hour-long webinar will be broadcast on Tuesday, March 30, 2010 at 1:00 p.m. ...
Cached Medicine News:Health News:EyeView Launches Innovative Video Marketing Quiz 2Health News:EyeView Launches Innovative Video Marketing Quiz 3Health News:Promega - TOP srl Agreement Enables Live Animal Imaging for Cancer Studies 2Health News:Wanted: Indianapolis Customer Service Professionals 2Health News:Wanted: Indianapolis Customer Service Professionals 3Health News:Wanted: Indianapolis Customer Service Professionals 4Health News:Wanted: Indianapolis Customer Service Professionals 5Health News:World's First 3D Dance DVD Released! 2Health News:World's First 3D Dance DVD Released! 3Health News:Cost of Junk Food May Influence Consumption 2Health News:Morehead Webinar to Discuss Building Workforce Commitment 2
... unique DHEA-S-7kits feature a ... against the C-7 position ... with no cross-reactivity with ... RIA has been optimized ...
... based on the competition principle and the ... present in the sample and a fixed ... compete for the binding sites of a ... After one hour incubation the microtiterplate is ...
Inquire...
... It is a compact Latex based reagent kit ... well as to determine the level of RF ... patient sera. The kit includes antigen coated fine ... control sera in plastic squeezable dropping bottles, re-usable ...
Medicine Products: